Filing Flows › Repligen (RGEN) › Q1 2026
Repligen (RGEN) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 6, 2026
Repligen (RGEN) reported revenue of $194M for the first quarter 2026 (Q1 2026), +15% from a year earlier and -2% from the quarter before. Operating margin was 8.2%, net earnings $8.3M (4.3% of revenue).
Repligen, Q1 2026: revenue $194M (+15% year over year), operating margin 8.2%, net earnings $8.3M, operating cash flow $28.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $194M | -2% | +15% |
| Operating profit | $15.9M | -11% | +142% |
| Net earnings | $8.3M | -37% | +43% |
| Operating cash flow | $28.3M | +10% | +89% |
| Free cash flow | $23.6M | +34% | +106% |
What changed
Revenue was $194.3M in Q1 2026, up 15% year over year and down 2% from the previous quarter. Product was the largest line at 100% of revenue. Product added $25.1M year over year (up 15%), 100% of the total change.
Operating profit was $15.9M, a 8.2% margin (up 4.3 points year over year). Of the extra revenue versus Q1 2025, 37% reached operating profit, above the 4% margin then. Total costs grew 10% against revenue growth of 15%. The fastest-growing cost line was Research & development (+19%). Net earnings were $8.3M, up 43% year over year. The tax line was a benefit of $6.6M on pre-tax earnings of $1.8M.
Operating cash flow was $28.3M (up 89% year over year), 340% of net earnings. Non-cash charges added back $19.8M of depreciation and amortization and $8.3M of share-based compensation. Working capital and other items used $8.1M. Capital expenditures of $4.7M left free cash flow of $23.6M.
Questions
What was Repligen's revenue in the first quarter 2026?
Repligen (RGEN) reported revenue of $194M for the first quarter 2026 (Q1 2026), +15% from a year earlier and -2% from the quarter before.
Was Repligen profitable in the first quarter 2026?
Operating profit was $15.9M (8.2% of revenue) and net earnings $8.3M.
Source: Repligen 10-Q on SEC EDGAR.